关注
Peter Gottlieb
Peter Gottlieb
未知所在单位机构
在 cuanschutz.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
W Liu, AL Putnam, Z Xu-Yu, GL Szot, MR Lee, S Zhu, PA Gottlieb, ...
The Journal of experimental medicine 203 (7), 1701-1711, 2006
35082006
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
JM Wenzlau, K Juhl, L Yu, O Moua, SA Sarkar, P Gottlieb, M Rewers, ...
Proceedings of the National Academy of Sciences 104 (43), 17040-17045, 2007
12962007
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
MD Pescovitz, CJ Greenbaum, H Krause-Steinrauf, DJ Becker, ...
New England Journal of Medicine 361 (22), 2143-2152, 2009
11342009
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association
RA Insel, JL Dunne, MA Atkinson, JL Chiang, D Dabelea, PA Gottlieb, ...
Diabetes care 38 (10), 1964-1974, 2015
10572015
Autoimmune polyendocrine syndromes
GS Eisenbarth, PA Gottlieb
New England Journal of Medicine 350 (20), 2068-2079, 2004
8492004
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
KC Herold, BN Bundy, SA Long, JA Bluestone, LA DiMeglio, MJ Dufort, ...
New England Journal of Medicine 381 (7), 603-613, 2019
7982019
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
T Orban, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 378 (9789), 412-419, 2011
6052011
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
DK Wherrett, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 378 (9788), 319-327, 2011
4032011
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic …
KC Herold, SE Gitelman, MR Ehlers, PA Gottlieb, CJ Greenbaum, ...
Diabetes 62 (11), 3766-3774, 2013
3982013
Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells
EM Bradshaw, K Raddassi, W Elyaman, T Orban, PA Gottlieb, SC Kent, ...
The Journal of Immunology 183 (7), 4432-4439, 2009
3402009
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data
CJ Greenbaum, CA Beam, D Boulware, SE Gitelman, PA Gottlieb, ...
Diabetes 61 (8), 2066-2073, 2012
3262012
Testing the NKT cell hypothesis of human IDDM pathogenesis
PT Lee, A Putnam, K Benlagha, L Teyton, PA Gottlieb, A Bendelac
The Journal of clinical investigation 110 (6), 793-800, 2002
3222002
Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes
AK Alkanani, N Hara, PA Gottlieb, D Ir, CE Robertson, BD Wagner, ...
Diabetes 64 (10), 3510-3520, 2015
3012015
No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes
T Brusko, C Wasserfall, K McGrail, R Schatz, HL Viener, D Schatz, ...
Diabetes 56 (3), 604-612, 2007
3012007
Autoantibody “subspecificity” in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups
JM Barker, J Yu, L Yu, J Wang, D Miao, F Bao, E Hoffenberg, JC Nelson, ...
Diabetes care 28 (4), 850-855, 2005
2892005
Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis–related diabetes: a technical review
A Moran, D Becker, SJ Casella, PA Gottlieb, MS Kirkman, BC Marshall, ...
Diabetes care 33 (12), 2677, 2010
2812010
B-lymphocyte depletion with rituximab and β-cell function: two-year results
MD Pescovitz, CJ Greenbaum, B Bundy, DJ Becker, SE Gitelman, ...
Diabetes care 37 (2), 453-459, 2014
2802014
CD4+ CD25high regulatory T cells in human autoimmune diabetes
AL Putnam, F Vendrame, F Dotta, PA Gottlieb
Journal of autoimmunity 24 (1), 55-62, 2005
2762005
Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes
M Battaglia, S Ahmed, MS Anderson, MA Atkinson, D Becker, PJ Bingley, ...
Diabetes care 43 (1), 5-12, 2020
2692020
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
MR Rigby, KM Harris, A Pinckney, LA DiMeglio, MS Rendell, EI Felner, ...
The Journal of clinical investigation 125 (8), 3285-3296, 2016
2662016
系统目前无法执行此操作,请稍后再试。
文章 1–20